- Home
- AMS vs TRIB Comparison
AMS vs TRIB Comparison
Compare AMS & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- TRIB
- Stock Information
- Founded
- AMS 1980
- TRIB 1992
- Country
- AMS United States
- TRIB Ireland
- Employees
- AMS N/A
- TRIB N/A
- Industry
- AMS Medical Specialities
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AMS Health Care
- TRIB Health Care
- Exchange
- AMS Nasdaq
- TRIB Nasdaq
- Market Cap
- AMS 19.5M
- TRIB 15.8M
- IPO Year
- AMS N/A
- TRIB N/A
- Fundamental
- Price
- AMS $3.09
- TRIB $1.39
- Analyst Decision
- AMS
- TRIB
- Analyst Count
- AMS 0
- TRIB 0
- Target Price
- AMS N/A
- TRIB N/A
- AVG Volume (30 Days)
- AMS 19.9K
- TRIB 166.9K
- Earning Date
- AMS 11-13-2024
- TRIB 11-15-2024
- Dividend Yield
- AMS N/A
- TRIB N/A
- EPS Growth
- AMS 566.31
- TRIB N/A
- EPS
- AMS 0.66
- TRIB N/A
- Revenue
- AMS $23,104,000.00
- TRIB $58,652,000.00
- Revenue This Year
- AMS $29.39
- TRIB $17.64
- Revenue Next Year
- AMS $16.22
- TRIB $9.84
- P/E Ratio
- AMS $4.30
- TRIB N/A
- Revenue Growth
- AMS 13.49
- TRIB 8.60
- 52 Week Low
- AMS $2.32
- TRIB $1.05
- 52 Week High
- AMS $4.60
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- AMS 47.64
- TRIB 42.63
- Support Level
- AMS $2.85
- TRIB $1.49
- Resistance Level
- AMS $3.24
- TRIB $1.70
- Average True Range (ATR)
- AMS 0.14
- TRIB 0.16
- MACD
- AMS -0.02
- TRIB -0.03
- Stochastic Oscillator
- AMS 58.54
- TRIB 5.56
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.